Liu Shi Xin

Nowe
40 lat doświadczenia
Lokalizacja: Chiny, Xiamen
Klinika:Szpital Xiamen Humanity
Professor Shixin Liu, MD, PhD, is the Discipline Leader of the Oncology Center. He is the former President of Jilin Provincial Cancer Hospital and former Director of the Cancer Prevention and Treatment Research Institute. He is a second-level professor and doctoral supervisor. He has received the State Council Special Government Allowance, the 4th National Famous Doctor (Outstanding Contribution) award, and the Model of Medical Ethics honor.

He specializes in the comprehensive diagnosis and treatment of malignant tumors. His focus is precision radiotherapy for thoracic and abdominal cancers. He is skilled in IMRT, VMAT, and SBRT for lung, esophageal, breast, and rectal cancers.

His leadership roles include Vice Chair of CMA Radiation Oncology, CACA Radiotherapy, and CACA Particle Therapy. He serves on the CSCO Standing Committee and as Vice Chair of the CSCO Radiation Oncology Expert Committee. He is Vice Chair of CPAM Radiation Oncology and a Standing Committee member of CSMEA. He chairs the Jilin Medical Association Radiation Oncology branch. He is on the editorial boards of the Chinese Journal of Radiation Oncology and the Practical Journal of Cancer.
Przeczytać więcej

Nowe

Wizyta u lekarza

Cena na zapytanie

Bookimed Insights: Najlepsi specjaliści od gruczolakoraka w Chinach ()

Bookimed skoordynował 1 zapytań dotyczących leczenia w Chinach, współpracując z 1 specjalistami. Lekarze w tej tabeli są wybierani na podstawie międzynarodowych kwalifikacji, doświadczenia klinicznego i wyników leczenia. Ranking za 2026 powstał w oparciu o zweryfikowane dane z rzeczywistych przypadków pacjentów i aktualne programy naszych partnerskich klinik.

Miejsce	Lekarz	doświadczenie	Odpowiedni dla	Czym się wyróżniają	Klinika i lokalizacja	Konsultacja

FAQ

To pytania od prawdziwych pacjentów poszukujących pomocy medycznej przez Bookimed. Odpowiedzi udzielają doświadczeni lekarze-koordynatorzy oraz oficjalni przedstawiciele klinik.

What innovative treatments are available for adenocarcinoma in China that might not be available elsewhere?

China offers unique adenocarcinoma treatments including CAR-T therapy for solid tumors and early-access oncolytic viruses. Facilities like Fuda Cancer Hospital specialize in minimally invasive cryoimmunotherapy for advanced stages. These protocols often receive regulatory approval years before Western markets. Patients access specific therapies targeting the Claudin18.2 protein.

Solid tumor CAR-T: Targets specific proteins in gastric and pancreatic adenocarcinomas.
Cryoimmunotherapy: Combines tumor freezing with immunotherapy to trigger systemic immune responses.
Oncolytic viruses: Genetically modified viruses specifically infect and destroy glandular cancer cells.
Advanced radiosurgery: The CyberKnife M6 system provides non-invasive treatment for precise tumor targeting.

Bookimed Expert Insight: China is a hub for late-stage cancer care because facilities like Fuda Cancer Hospital combine over 10 types of minimally invasive therapies. Our data shows hospitals here often manage 1,000,000 patients annually. This high volume allows surgeons to refine techniques like NanoKnife and microwave hyperthermia faster than in lower-volume regions. This practical experience is vital for complex adenocarcinoma cases.

Patient Consensus: Patients note that seeking treatment in China often provides earlier access to experimental therapies through active clinical trials. Many emphasize the importance of consulting both local and international oncologists to verify efficacy data before starting newer immunotherapy combinations.

Can Traditional Chinese Medicine (TCM) be integrated with standard adenocarcinoma treatments?

Traditional Chinese Medicine (TCM) is frequently integrated with standard adenocarcinoma treatments in China to enhance outcomes. This integrated approach combines Western tumor-targeting therapies with TCM's holistic focus. It helps mitigate side effects like nausea or fatigue from chemotherapy while supporting the patient’s immune system through recovery.

Targeted synergy: TCM herbs may act as sensitizers for chemotherapy or radiotherapy efficacy.
Symptom management: Acupuncture and herbal formulas help reduce postoperative pain and appetite loss.
Integrated protocols: Standard treatments like CyberKnife M6 are often paired with supportive herbal medicine.
Advanced diagnostics: Clinics utilize PET/CT and scintigraphy alongside traditional pulse and tongue analysis.

Bookimed Expert Insight: Patient data from Jinshazhou Hospital of Guangzhou University of Chinese Medicine reveals a significant trend where advanced technologies like CyberKnife M6 are physically housed within TCM-affiliated institutions. This proximity suggests that integration isn't just a philosophy but a structural reality in China. For around $7,700, patients can access high-precision radiosurgery packages that already include the necessary medical consultations for a combined treatment plan.

Patient Consensus: Patients emphasize that TCM should be a side-by-side support rather than a replacement for surgery or chemotherapy. Many note it is essential to disclose herbal use to oncologists to avoid potential liver metabolism interactions.

Which cities and hospitals are considered best for cancer care in China?

Beijing, Shanghai, and Guangzhou are the primary hubs for cancer care in China. These cities host national centers like the Cancer Hospital of the Chinese Academy of Medical Sciences. Facilities often feature Joint Commission International (JCI) accreditation and specialize in advanced therapies like CyberKnife and NanoKnife.

Beijing leadership: Home to the National Cancer Center with the highest reported survival rates.
Guangzhou expertise: Jinshazhou Hospital offers advanced CyberKnife M6 stereotactic radiosurgery for targeted treatment.
Shanghai specialization: Fudan University Shanghai Cancer Center excels in adenocarcinoma and genomic profiling.
Patient capacity: Xiamen Humanity Hospital manages over 1,000,000 patients annually with 1,000 beds.

Bookimed Expert Insight: Guangzhou holds a unique position for international patients due to a concentration of minimally invasive technologies. Fuda Cancer Hospital has treated over 30,000 international patients using specialized cryosurgery and NanoKnife protocols. While Beijing centers focus on national research, Guangzhou clinics often provide more accessible high-tech packages. For instance, CyberKnife M6 treatments in the region cost around $7,700 and include transfers and hotel stays.

Patient Consensus: Patients emphasize bringing original pathology slides to avoid diagnostic delays. They note that JCI-accredited facilities provide better English support and more organized care transitions for international visitors.

What is required for payment or insurance coverage as a foreign patient?

Foreign patients in China usually pay 100% upfront for adenocarcinoma treatments. Most hospitals require proof of funds for admission. Large payments typically move via wire transfer, Alipay, or WeChat Pay. International health insurance often requires pre-authorization 2 to 4 weeks before arrival.

Payment timing: Full estimated costs are typically required before treatment begins.
Local currency: Hospitals prioritize Renminbi (RMB) for all major inpatient transactions.
Insurance approval: Most global insurers must approve medical reports before travel.
Billing documents: Always request detailed, itemized invoices in English for reimbursement.

Bookimed Expert Insight: CyberKnife M6 packages in Guangzhou, costing approximately 56,000 CNY, often exclude hospital stays. Our data shows specialized centers like Fuda Cancer Hospital serve 30,000+ international patients. These JCI-accredited facilities often require separate budgeting for hotel accommodation. Always confirm which services are bundled to avoid payment delays.

Patient Consensus: Patients note that foreign credit cards often fail for large medical bills. They recommend having high-limit bank transfers or local mobile payment apps ready. Many found that international insurers might label certain advanced therapies as experimental, making upfront cash essential.

How are language barriers and logistics handled for international patients?

Chinese hospitals manage international patients through dedicated international departments providing on-site medical interpreters and JCI-accredited coordination services. Logistics often include visa assistance, airport transfers, and digital communication tools like WeChat groups. Integrated packages typically bundle surgical consultations, medication, and local transportation for seamless care.

Language support: On-site interpreters facilitate communication between patients, physicians, and nursing staff.
Logistics management: International departments oversee airport pickups, clinical transfers, and medical visa documentation.
Coordinated packages: Specialized bundles include hospital stays, hotel proximity, and pre-treatment video consultations.
Digital integration: Clinics use real-time messaging apps to provide progress updates and administrative help.

Bookimed Expert Insight: While top-tier facilities like Fuda Cancer Hospital serve thousands of international patients, logistics vary by city. Packages at Jinshazhou Hospital in Guangzhou often include clinic transfers. However, Xiamen Humanity Hospital serves nearly 1,000,000 patients annually. Choosing high-volume centers ensures streamlined administrative protocols for foreign medical records and faster visa processing.

Patient Consensus: Patients note that doctors often speak fluent English, but nursing staff may not. They recommend setting up digital payment apps and hiring local student fixers to help navigate daily hospital bureaucracy.

Najlepsi lekarze do leczenia gruczolakoraka w Xiamenie – TOP 1 lekarz

Uzyskaj oferty od 3 najlepszych specjalistów w Chiny